> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Qiagen QIAstat-Dx Respiratory Panel Cleared
- URL: https://www.fdaweb.com/qiagen-qiastat-dx-respiratory-panel-cleared/
- Published: 2019-05-20T12:00:00.000Z
- Updated: 2026-09-15T01:27:42.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144145

FDA has cleared a Qiagen 510(k) for the multiplex QIAstat-Dx Respiratory Panel for simultaneous qualitative detection and identification of multiple respiratory viral and bacterial pathogens. The next-generation multiplex molecular diagnostic system, which is based on the company’s proprietary DiagCore technology, can detect more than 20 pathogens. The panel is the first test from Qiagen pipeline of planned assays for QIAstat-Dx in the U.S., the company says, adding that it plans to launch a gastrointestinal panel later in 2019.